New York, NY USA

Our News on Newswise

The Newest Precision Medicine Tool: Prostate Cancer Organoids

Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting new tool to test cancer...
29-Aug-2014 11:00 AM EDT

Medical Director Appointed at Memorial Sloan Kettering’s Locations in Westchester, New Jersey, and Long Island

Ephraim Casper, MD, has been appointed Medical Director for the Memorial Sloan Kettering Regional Care Network, comprised of six outpatient suburban locations — three on Long Island; two in Westchester County, New York; and one in Basking Ridge,...
31-Jul-2014 2:00 PM EDT

Transplantation Shown to Be Highly Effective in Treating Immune Deficiency in Children

Babies who are born with severe combined immunodeficiency (SCID) can be successfully treated with a transplant of blood-forming stem cells, according to experts led by Memorial Sloan Kettering’s Richard J. O’Reilly, MD.
28-Jul-2014 12:00 PM EDT

Memorial Sloan Kettering Ranks First in the Nation for Cancer Care

Memorial Sloan Kettering Cancer Center is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals.
15-Jul-2014 8:00 AM EDT

Memorial Sloan Kettering Appoints Digitaslbi as Digital Agency of Record

Memorial Sloan Kettering Cancer Center (MSK) is partnering with DigitasLBi and Phase2 to help expand MSK’s digital reach.
20-Jun-2014 10:00 AM EDT

Memorial Sloan Kettering Cancer Center and Quest Diagnostics Partner to Advance Precision Medicine in Cancer Diagnosis and Treatment

Memorial Sloan Kettering Cancer Center and Quest Diagnostics announced a joint collaboration that will utilize MSK’s clinical and research insights into gene mutations associated with solid tumors. The goal is to use molecular laboratory testing...
1-Jun-2014 9:00 AM EDT

Study Using Comprehensive Genomic Tumor Testing to Match Lung Cancer Patients with Targeted Therapies Transforms Care

New data from a study led by Memorial Sloan Kettering physicians that used targeted therapy for patients with the most common type of lung cancer has helped transform treatment for the disease.
16-May-2014 2:00 PM EDT

Landmark Gift of $100 Million from the Marie-Josée and Henry R. Kravis Foundation Will Support Groundbreaking Approach to Precision Oncology

140516__130.jpg

Memorial Sloan Kettering Cancer Center launched the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, an ambitious initiative to improve cancer care and research through genomic analysis.
20-May-2014 8:00 AM EDT

Our YouTube Videos